Lung Cancer, Smoking Cessation
Conditions
Keywords
Smoking Habits
Brief summary
The proposed study plans to adapt and study the implementation and effectiveness of integrating Clinical and Community Effort Against Secondhand smoke Exposure (CEASE) into the thoracic oncology setting using mixed methods.
Detailed description
In particular the study aims to see if participants are asked about their smoking status and what services are offered if someone indicates being a former or current smoker. Findings from this study will help improve a standard of care at this clinic and allow us to understand what type of tobacco treatment services are preferred by patients. * Adaption of CEASE will entail exit interviews with patients and individual interviews with clinical staff to identify and address facilitators and barriers to the implementation process. * Effectiveness of CEASE will be measured through questionnaires & biochemical verification of smoking status using a pre-test/post-test study design before (usual care)and after implementation (CEASE)
Interventions
OTHERCEASE
* Clinical and Community Effort Against Secondhand Smoke Exposure (CEASE) * CEASE is a system-level intervention that integrates tobacco-use screening, cessation assistance, and referral to outside services into routine visits
OTHERUsual Care Tobacco Treatment Services
Sponsors
Dana-Farber Cancer Institute
Brigham and Women's Hospital
Massachusetts General Hospital
Study design
Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥ 18 * Have an actual or potential diagnosis of thoracic malignancy * Able to read and write in English. * Current or recent former smoker (defined as having smoked within past 6 months) * Must have an active telephone number.
Exclusion criteria
* Former smoker greater than 6 months. * Have any of the below conditions needing immediate medical intervention * Hypercalcemia causing lethargy and confusion, * Acute respiratory distress * Dehydration * Hypotension
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Smoking cessation Rate | 6 Months | Biochemical verification of smoking cessation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Documentation of tobacco treatment | 2 months after CEASE | Assess documentation of smoking assessment and provision of treatment ( medication and referral for behavioral counseling) |
Countries
United States
Contacts
PRINCIPAL_INVESTIGATORMary E Cooley, PhD, RN
Dana-Farber Cancer Institute
Outcome results
None listed